Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (53,271)	$ (44,016)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	39,460	35,449
Deferred income taxes	26,921	(3,929)
Goodwill impairment	0	28,453	[1]
Impairment of long-lived assets	494	581
Share-based compensation expense	9,767	11,107
Other	724	1,225
Changes in working capital and other assets and liabilities:
Accounts receivable	1,371	(16,958)
Inventories	(143,647)	(61,086)
Prepaids and other current assets	(10,828)	(17,718)
Accounts payable	99,322	44,551
Other accrued liabilities	6,051	(3,454)
Other assets and liabilities	(5,472)	2,255
Net cash used in operating activities	(29,108)	(23,540)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(27,397)	(49,738)
Proceeds from asset sales	1	87
Net cash used in investing activities	(27,396)	(49,651)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under revolving credit facility	344,303	365,416
Payments on revolving credit facility	(278,779)	(282,083)
Shares repurchased related to share repurchase plan	(9,789)	(32,027)
Shares repurchased related to taxes for share-based awards	(2,074)	(2,249)
Change in overdraft balances	882	(1,847)
Other	0	(12)
Net cash provided by financing activities	54,543	47,198
Effect of foreign exchange rate fluctuations on cash	384	(306)
Net decrease in cash	(1,577)	(26,299)
Cash at beginning of period	35,155	47,990
Cash at end of period	33,578	21,691
Supplemental information:
Interest paid	3,290	5,711
Income taxes paid	$ 2,275	$ 5,487

[1] Goodwill impairment of $28.5 million is related to Genesco Brand Group.